XERS compared with ARVN: revenue, margins and what each company keeps, and the suppliers and customers both name

XERSXeris Biopharma Holdings, Inc.

Mkt capRevenueRevenue

ARVNArvinas, Inc.

Mkt capRevenueRevenue

Compare

XERSXeris Biopharma Holdings, Inc.

ARVNArvinas, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

XERSXeris Biopharma Holdings, Inc.

10.14· pre 10.12· delayed

Mkt cap$2.0BRevenue$92MQ2 FY26Revenue$292MFY25

ARVNArvinas, Inc.

7.53· pre 7.30· delayed

Pre-marketNov 3 '26delayed

Mkt cap$491.7MRevenue$250MQ2 FY26Revenue$263MFY25

Compare

Pre-marketNov 3 '26delayed

XERSXeris Biopharma Holdings, Inc.

ARVNArvinas, Inc.

10.14pre 10.12delayed

Price

7.53pre 7.30delayed

$2.0B

Mkt cap

$491.7M

Q2 FY26$92M

Revenue

$250MQ2 FY26

FY25$292M

Revenue

$263MFY25

XERS10.14vsARVN7.53Pre-marketNov 3 '26delayed

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

XERS: latest quarter is a loss; flow not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only XERS 11

—Bachem Americasunlistedsupplier

—Lonza Tampaunlistedsupplier

—Pyramid Laboratoriesunlistedsupplier

—Regis Technologiesunlistedsupplier

7 more · XERS chain ›

Shared 0

No shared counterparties.

Only ARVN 4

PFEPfizercustomer

NVSNovartis Pharmacustomer

—Yale Universityunlistedsupplier

—Bayer

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

unlisted

customer

Price

rebased to 0%

XERS, solidARVN, dashed